Nevro Names Kevin Thornal as New Chief Executive Officer and President

Redwood City, CA, April 19, 2023 (PRNewswire) -- Nevro Corp., a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that Kevin Thornal has been appointed Chief Executive Officer and President of Nevro, effective April 24, 2023, and will also be appointed to the Board of Directors. Mr. Thornal succeeds D. Keith Grossman, who is retiring as Chief Executive Officer and President, also effective April 24, 2023. Mr. Grossman will be appointed to serve as Executive Chairman. The company also announced its preliminary, unaudited revenue for the first quarter of 2023 and reaffirmed its full-year 2023 guidance provided on February 16, 2023.

Read full article here.